Delivery Order SPE2DB20D3303-SPE2DB24FZ2G3
Award Date
3/20/24
Potential Completion Date
3/21/24
Potential Value
$24K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply DUPIXENT 300 MG/2 ML PEN 2ML medical products. The $35,276.49 award has a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 2025. This...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The contract has a potential value of $5,924.27 and a completion date of January 30, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not associated with any set-aside designation. Amerisourcebergen Drug Corp also holds an...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The contract has a potential ceiling value of $42,263.48 and a performance period through April 11, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued up to...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $8,266.70 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This delivery order is for the provision of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The contract has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp is also the prime contractor on an indefinite delivery contract (IDC) with DLA Troop Support Medical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 4,564,205,110 units of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. The delivery order, valued at $26,135.63, has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA that serves as the primary contract vehicle for the company to...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $3,885.26 to provide DUPIXENT 300 MG/2 ML PEN 2ML pharmaceutical products. The contract has a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not associated with any set-aside program. This delivery order is issued under a larger indefinite delivery contract...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies. The $4,114.82 firm fixed price contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, with a performance period ending on May 13, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DUPIXENT 300 MG/2 ML PEN 2ML pharmaceuticals. The award, valued at $5,921.36, has a completion date of February 28, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which is not associated with any set-aside program. This delivery order is issued under a larger indefinite delivery contract (IDC)...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a delivery order contract valued at $10,260.96 to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of DUPIXENT 300 MG/2 ML PEN 2ML, a pharmaceutical product, with a period of performance through May 29, 2024. This order was placed under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $13,655.88 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,184,849 units of the pharmaceutical product DUPIXENT 300 MG/2 ML PEN 2ML. This order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime contractor. The IDC enables Amerisourcebergen to deliver a comprehensive range of...